The Claim

Elevated plasma matrix metalloproteinase 7 (MMP7) levels are associated with increased odds of incident mild cognitive impairment or dementia over 24 months in older adults aged 70–80 at high risk of mobility disability, with individuals in the highest quartile of MMP7 exhibiting more than double the risk (OR = 2.14, 95% CI: 1.28–3.65) compared to those in the lowest quartile.

Source: Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
83score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Older adults aged 70–80 at high risk of mobility disability who have higher levels of MMP7 in their blood are more likely to develop mild cognitive impairment or dementia within two years than those with lower levels.

See the scientific wording

Elevated plasma matrix metalloproteinase 7 (MMP7) is associated with increased odds of incident mild cognitive impairment or dementia over 24 months in older adults aged 70–80 at high risk of mobility disability, with those in the highest quartile having more than double the risk (OR = 2.14, 95% CI: 1.28–3.65) compared to the lowest quartile, suggesting MMP7 may be a longitudinal biomarker of cognitive decline in this population.

Why this might work

High levels of MMP7 in the blood break down the protective barrier around the brain, allowing immune cells and harmful substances to enter. This triggers chronic inflammation in the brain, which damages nerve connections and kills brain cells, leading to memory problems and dementia.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Biomarkers of cellular senescence predict risk of mild cognitive impairment: Results from the lifestyle interventions for elders (LIFE) study

    Older adults with higher levels of a blood protein called MMP7 were more than twice as likely to develop memory problems within two years, according to this study. This suggests MMP7 could help doctors spot who might be at higher risk for dementia.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.